Experts call for stepped-up hepatitis battle

July 24, 2014

The world can beat the cancer-causing disease hepatitis if it raises its game, but treatment programmes need to go hand in hand with those tackling the likes of HIV, experts said Thursday.

Viral hepatitis is a group of infectious diseases known by the letters A, B, C, D or E, which attack the liver.

Despite killing close to 1.4 million people every year—with Asia the hardest-hit region—hepatitis has long failed to grab the spotlight.

Ninety percent of deaths are from hepatitis B and C, responsible for two-thirds of the global liver cancer toll.

"It's a no-brainer. The best way to prevent liver cancer or people dying from is to prevent and treat ," said Samuel So, a liver surgeon and professor at Stanford University in California.

"If you do that, you'll save a lot of lives and a lot of healthcare costs," he told reporters in Geneva.

Hepatitis B and C are transmitted from infected mothers to newborn babies, by unsafe injections during medical procedures and drug use, or unsafe sex.

"Finally we're seeing some real momentum building," said Stefan Wiktor, leader of the hepatitis programme at the World Health Organization.

Testing is crucial, given that of the estimated 500 million people with viral hepatitis, many are unaware of their infection.

"We also need to make sure there is prevention in place, that healthcare-associated transmission is reduced, that injecting drug users to the equipment they need to prevent from getting infected," Wiktor told reporters.

Hepatitis C, notably, is undergoing a "therapeutic revolution", Wiktor said, with new medicines offering a cure rate of 95 percent.

"That totally changes the dynamic about how we should approach this," he added.

Hepatitis kills almost as many people a year as HIV/AIDS, and therefore needs a similar degree of international traction, said So.

People affected by HIV are also particularly vulnerable to hepatitis, with up to 10 million worldwide estimated to be infected with both.

Advances in HIV treatment have prolonged the lives of people with that virus, meaning they have more time to develop hepatitis-related , but hepatitis treatment still lags behind.

"The structure we created for HIV treatment is ideal for hepatitis treatment. It's time that we didn't put these diseases into silos," So said.

Explore further: Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia

Related Stories

Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia

April 17, 2014
The analysis was conducted by Dr Benjamin Cowie and Ms Jennifer MacLachlan from the University of Melbourne and Melbourne Health, and was presented at The International Liver Congress in London earlier this month.

Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

March 17, 2014
A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from ...

Hepatitis C screening for baby boomers

April 29, 2013
If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. The word "hepatitis" means swelling of the liver. Hepatitis is most often caused by a virus. In the United States, the most common ...

Hepatitis C kills more Americans than HIV: study

February 23, 2012
More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.

Hepatitis C cured in co-infected HIV patients

July 19, 2014
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.

WHO urges global push to treat hepatitis C (Update)

April 9, 2014
The World Health Organization called Wednesday for a dramatic increase in screening and treatment of hepatitis C, saying higher demand would help drive down the cost of drugs for the disease.

Recommended for you

Two Group A Streptococcus genes linked to 'flesh-eating' bacterial infections

September 22, 2017
Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known ...

Ecosystem approach makes urinary tract infection more treatable

September 22, 2017
The biological term 'ecosystem' is not usually associated with urinary tract infections, but this should change according to Wageningen scientists.

Residents: Frontline defenders against antibiotic resistance?

September 22, 2017
Antibiotic resistance continues to grow around the world, with sometimes disastrous results. Some strains of bacteria no longer respond to any currently available antibiotic, making death by infections that were once easily ...

Individualized diets for irritable bowel syndrome better than placebo

September 21, 2017
Patients with irritable bowel syndrome who follow individualized diets based on food sensitivity testing experience fewer symptoms, say Yale researchers. Their study is among the first to provide scientific evidence for this ...

Superbug's spread to Vietnam threatens malaria control

September 21, 2017
A highly drug resistant malaria 'superbug' from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine—Vietnam's national first-line malaria treatment, ...

A dose of 'wait-and-see' reduces unnecessary antibiotic use

September 21, 2017
Asking patients to take a 'wait-and-see' approach before having their antibiotic prescriptions filled significantly reduces unnecessary use, a University of Queensland study has shown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.